StockGlow

TELA Bio, Inc. (TELA)

Makes tissue patches from sheep material to repair hernias and abdominal wounds.

$0.67+0.03%Healthcare
Compare TELA with
StockGlow Score
23
Leaning Bearish
BearishBullish
1 year ago-64.0%

The outlook

TELA is trading near its 52-week lows, well below both short- and long-term moving averages, reflecting downward price momentum. Analysts on average see significant upside, with targets around 236% above the current price, though the stock's recent trend and overall bearish lean suggest caution. Coverage leans heavily bullish on fundamentals, but current technicals show weakness.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range10% of the way from its 52-week low to high
Price targetAvg target +236% vs current price

Analyst price target

~12-month · 5 analysts
$2.25average target+235.8% vs now
Now $0.67
Low $1.00High $3.25

Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.

Market cap
$30.0M
52-wk high
$2.14
52-wk low
$0.50
50-day avg
$0.82
200-day avg
$0.95
Trailing P/E
—

Similar stocks

XGNExagen Inc.$4.45+1.14%SIBNSI-BONE, Inc.$17.93+5.16%APYXApyx Medical Corporation$3.86-0.77%VRCAVerrica Pharmaceuticals Inc.$5.40+2.08%STROSutro Biopharma, Inc.$23.73-1.17%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy